| Ampol Limited (ALD) ORDINARY FULLY PAID |
Energy |
$8,102 |
Appendix 3Y - Matthew Halliday
|
29 Apr 2025 10:18AM |
$22.650 |
$34.000 |
risen by
50.11%
|
|
| ReNerve Limited (RNV) ORDINARY FULLY PAID |
Health Care |
$13 |
Quarterly Investor Webinar
|
29 Apr 2025 10:16AM |
$0.105 |
$0.095 |
fallen by
9.52%
|
|
| Peoplein Limited (PPE) ORDINARY FULLY PAID |
Industrials |
$66 |
Change in substantial holding
|
29 Apr 2025 10:15AM |
$0.800 |
$0.605 |
fallen by
24.38%
|
|
| identitii Limited (ID8) ORDINARY FULLY PAID |
Information Technology |
$6 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Apr 2025 10:15AM |
$0.007 |
$0.007 |
fallen by
0%
|
|
ID8 - Price-sensitive ASX Announcement
Full Release
Key Points
- BNDRY repositioning continues to gather pace and momentum
- New agreement with Cherry Hub to service hospitality venues, clubs and hotels
- Three proof-of-concept agreements signed with well-known payments companies
- Significant new interest from large Tranche 2 sector
- Tim Phillipps appointed Executive Chair
- Payments to suppliers and employees of $1.23M, stable q/o/q
- R&D Tax Incentive Rebate of $982K received
- Renewed Mitchell Asset Management term loan facility of $888K
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Radiopharm Theranostics Limited (RAD) ORDINARY FULLY PAID |
Health Care |
$71 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Apr 2025 10:15AM |
$0.022 |
$0.020 |
fallen by
9.09%
|
|
RAD - Price-sensitive ASX Announcement
Full Release
Key Points
- Lantheus increases to 12.16% shareholding in Radiopharm.
- Successful detection of brain metastases using RAD 101.
- Data on RAD202 presented at European Molecular Imaging Meeting confirms specific tumor accumulation.
- Participation in prominent US investment conferences.
- Cash flow guidance remains on track to June 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Burgundy Diamond Mines Limited (BDM) ORDINARY FULLY PAID |
Materials |
$24 |
First quarter investor call
|
29 Apr 2025 10:14AM |
$0.039 |
$0.017 |
fallen by
56.41%
|
|
| MedAdvisor Limited (MDR) ORDINARY FULLY PAID |
Health Care |
- |
MedAdvisor Solutions 3Q FY25 Investor Webinar
|
29 Apr 2025 10:14AM |
$0.096 |
$0.022 |
fallen by
77.08%
|
|
| Proteomics International Laboratories Ltd (PIQ) ORDINARY FULLY PAID |
Health Care |
$45 |
Notice Under Section 708A
|
29 Apr 2025 10:13AM |
$0.380 |
$0.275 |
fallen by
27.63%
|
|
| ReNerve Limited (RNV) ORDINARY FULLY PAID |
Health Care |
$13 |
ReNerve - Q3 FY25 Activities Report & Appendix 4C
|
29 Apr 2025 10:13AM |
$0.105 |
$0.095 |
fallen by
9.52%
|
|
RNV - Price-sensitive ASX Announcement
Full Release
Key Points
- ReNerve completed GMP manufacturing batches for its core nerve repair product portfolio.
- Progress was made toward regulatory submissions for the Nerve Repair Conduit (NRC) in Australia (TGA) and Europe (CE mark).
- Ongoing commercial partner engagement and market preparation activities were reported.
- Cash outflows for the quarter were primarily attributed to research and development and general operations.
- The company maintains sufficient cash reserves to fund short-term strategic initiatives.
- ReNerve outlined next steps focusing on commercialization, regulatory approvals, and advancing strategic partnerships.
- Research collaborations and product development continued to progress in line with planned timelines.
- No changes were reported in the use of funds compared to previous disclosures.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pacific Edge Limited (PEB) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$153 |
Triage Plus Set to Lift Pacific Edge's Economics
|
29 Apr 2025 10:12AM |
$0.075 |
$0.150 |
risen by
100%
|
|
PEB - Price-sensitive ASX Announcement
Full Release
Key Points
- Pacific Edge launches the Cxbladder Triage Plus test targeting improved detection of bladder cancer.
- The new test is CLIA certified in the US and designed for patients at low risk of bladder cancer.
- Triage Plus is expected to qualify for the higher US Medicare reimbursement rate.
- The test’s clinical value and increased adoption are anticipated to enhance Pacific Edge’s financial position.
- Pacific Edge is engaging with commercial payers and pursuing additional regulatory approvals.
- The company continues to focus on cost management, operational efficiency, and market expansion.
- Cash position and operational performance were reported as stable, with a forward-looking strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ampol Limited (ALD) ORDINARY FULLY PAID |
Energy |
$8,102 |
Notification regarding unquoted securities - ALD
|
29 Apr 2025 10:11AM |
$22.650 |
$34.000 |
risen by
50.11%
|
|
| Proteomics International Laboratories Ltd (PIQ) ORDINARY FULLY PAID |
Health Care |
$45 |
Notification regarding unquoted securities - PIQ
|
29 Apr 2025 10:11AM |
$0.380 |
$0.275 |
fallen by
27.63%
|
|
| Proteomics International Laboratories Ltd (PIQ) ORDINARY FULLY PAID |
Health Care |
$45 |
Application for quotation of securities - PIQ
|
29 Apr 2025 10:11AM |
$0.380 |
$0.275 |
fallen by
27.63%
|
|
| Austral Resources Australia Ltd (AR1) ORDINARY FULLY PAID |
Materials |
$172 |
Austral March 2025 Quarterly Report
|
29 Apr 2025 10:08AM |
$0.160 |
$0.081 |
fallen by
49.38%
|
|
AR1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Austral completed mining of the Anthill West Pit.
- Signed an MOU with New Frontier Minerals to increase production.
- Faced challenges from seasonal flooding and recapitalisation.
- Continued focus on expanding copper resources.
- Production was below target due to weather and mechanical problems.
- Maintained copper cathode purity at 99.999%.
- Actively pursuing potential mergers and acquisitions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| InteliCare Holdings Limited (ICR) ORDINARY FULLY PAID |
Health Care |
$12 |
Mecwacare Agreement
|
29 Apr 2025 10:08AM |
$0.007 |
$0.020 |
risen by
185.71%
|
|
ICR - Price-sensitive ASX Announcement
Full Release
Key Points
- InteliCare Holdings Limited (ICR) has entered into an agreement with Mecwacare, a leading Victorian aged care provider.
- The agreement covers the implementation of InteliCare’s AI-powered home monitoring systems in Mecwacare’s facilities and home care services.
- The contract is multi-year, enabling expansion if deployment proves successful.
- This partnership demonstrates market traction for InteliCare’s technology within the aged care sector.
- The agreement is expected to deliver significant recurring revenue for InteliCare.
- The collaboration is part of InteliCare’s strategy to drive commercial expansion and market presence in Australia.
- Both parties expect improved care outcomes through proactive monitoring and technology-enabled care solutions.
- The agreement marks a milestone in InteliCare’s commercial journey and confirms growing industry demand for smart care technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rent.com.au Limited (RNT) ORDINARY FULLY PAID |
Communication Services |
$58 |
Rights Issue Fully Complete
|
29 Apr 2025 10:07AM |
$0.016 |
$0.050 |
risen by
212.50%
|
|
RNT - Price-sensitive ASX Announcement
Full Release
Key Points
- Rights issue by Rent.com.au Limited (RNT) is fully complete.
- The rights issue was non-renounceable and targeted existing shareholders.
- New shares were offered to eligible shareholders at a fixed price and ratio.
- The offer successfully raised the intended capital.
- Allotment and issuance of new shares to shareholders is confirmed.
- The rights issue process is concluded and shares will be listed.
- The Board acknowledges shareholder and director support.
- Announcement date is June 13, 2024.
- Shareholders and investors may contact the company for more information.
- This completes the capital raising initiative announced earlier.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Amcor Plc (AMC) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$26,221 |
NYSE Announcement
|
29 Apr 2025 10:05AM |
$15.140 |
$56.750 |
risen by
274.83%
|
|
| USCOM Ltd (UCM) ORDINARY FULLY PAID |
Health Care |
$3 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Apr 2025 10:05AM |
$0.025 |
$0.012 |
fallen by
52%
|
|
UCM - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly activities and cash flow report for quarter ending 31 March 2023.
- Continued sales and market expansion of USCOM’s products, including Uscom 1A, BP+, and SpiroSonic.
- Progress in regulatory submissions and approvals in key markets such as Europe, China, and the US.
- Focus on research and development for next-generation medical devices.
- Partnerships and distribution agreements to enhance global market coverage.
- Financial summary includes customer receipts, operating expenditure, and end-of-quarter cash position.
- No payments made to related parties outside of director fees and standard reimbursements.
- Company remains focused on cash conservation and cost management.
- Outlook includes ongoing product sales, regulatory progress, and pursuit of new market opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Magnetite Mines Limited (MGT) ORDINARY FULLY PAID |
Materials |
$7 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Apr 2025 10:04AM |
$0.110 |
$0.038 |
fallen by
65.45%
|
|
MGT - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities Report and Appendix 5B Cash Flow Report released for period ending 31 December 2023.
- Progressed Razorback Iron Ore Project in South Australia, focusing on technical studies and environmental approvals.
- Advanced geological, mining, metallurgical, and infrastructure workstreams during the quarter.
- Continued stakeholder engagement with government, community, and industry participants.
- Reported cash outflows related to exploration and development, maintaining sufficient cash reserves.
- Company is actively working to secure project financing and progress towards project development.
- Focus on prudent financial management and strong governance throughout the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IDT Australia Limited (IDT) ORDINARY FULLY PAID |
Health Care |
$19 |
Quarterly Revenue Growth of 30% with $62M in Open Proposals
|
29 Apr 2025 10:04AM |
$0.110 |
$0.044 |
fallen by
60%
|
|
IDT - Price-sensitive ASX Announcement
Full Release
Key Points
- IDT Australia achieved 30% quarterly revenue growth in Q3 FY24.
- Revenue was driven by increases in both cGMP manufacturing and non-cGMP services.
- Open proposals pipeline exceeds $62 million, supporting future business prospects.
- Strategic investments in facility upgrades and service expansion are ongoing.
- The company reinforced its position as a key player in the Australian pharmaceutical sector.
- Management highlighted operational discipline and ongoing cost control initiatives.
- Focus remains on sustainable long-term growth and client relationship strengthening.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Verity Resources Limited (VRL) ORDINARY FULLY PAID |
Materials |
$10 |
Significant REE, Gallium and Titanium Anomalies at Pimenta
|
29 Apr 2025 10:03AM |
$0.013 |
$0.021 |
risen by
57.69%
|
|
VRL - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant REE, gallium, and titanium anomalies discovered at Pimenta Project in Minas Gerais, Brazil.
- Geochemical soil sampling identified elevated concentrations of critical minerals in lateritic soils and saprolite.
- Sampling results suggest the potential for ionic adsorption clay (IAC) style REE mineralisation.
- Key anomalies are located near existing infrastructure, enhancing project viability.
- Further exploration planned including additional soil sampling, auger drilling, and metallurgical testwork.
- The findings support the potential for economic extraction and justify advancing the exploration program.
- The Pimenta Project is situated in a geologically prospective area for REEs and associated critical minerals.
- VRL is focused on confirming IAC-style mineralisation, which is highly sought after for REE extraction.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Platina Resources Limited (PGM) ORDINARY FULLY PAID |
Materials |
$16 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Apr 2025 10:03AM |
$0.021 |
$0.025 |
risen by
19.05%
|
|
PGM - Price-sensitive ASX Announcement
Full Release
Key Points
- Platina Resources Limited's quarterly activities report focuses on the advancement of its PGM (platinum group metals) projects.
- The company provided updates on its portfolio, particularly the Munni Munni PGM project and the Xanadu Gold Project in Western Australia.
- Progress at the Munni Munni project included continued discussions with joint venture partners and steps to maximize value from the asset.
- At the Xanadu Gold Project, the company undertook technical reviews and outlined plans for future exploration and drilling activities.
- The report details the company's ongoing assessment of new project and investment opportunities in the resource sector.
- Financial highlights include a summary of the Appendix 5B Cash Flow Report for the quarter, with information on exploration expenditure, administrative costs, and cash balance.
- No mining production or development activities were undertaken during the quarter.
- The company's cash position and funding strategy were discussed, noting sufficient funds to support planned activities.
- Platina Resources maintained a focus on cost control and prudent financial management.
- Corporate activities included updates on board and management, as well as compliance with ASX listing rules.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Volt Resources Limited (VRC) ORDINARY FULLY PAID |
Materials |
$31 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Apr 2025 10:02AM |
$0.005 |
$0.006 |
risen by
33.33%
|
|
VRC - Price-sensitive ASX Announcement
Full Release
Key Points
- Volt Resources Limited reported on progress for the Bunyu Graphite Project in Tanzania.
- Ongoing operations and developments at Zavalievsky Graphite in Ukraine were detailed.
- Strategic focus was placed on battery anode material and downstream processing initiatives.
- Quarterly financials include cash flows, operating expenditures, and closing cash balance.
- Engagement with the Tanzanian government regarding mining activities continued.
- Technical and marketing activities for graphite products advanced during the quarter.
- Corporate actions included successful capital raising and share placements.
- Updates were provided on governance and regulatory compliance.
- The report includes an Appendix 5B outlining detailed cash flows.
- Volt Resources Limited remains focused on expanding and integrating its graphite business internationally.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Codrus Minerals Limited (CDR) ORDINARY FULLY PAID |
Materials |
$5 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Apr 2025 10:02AM |
$0.020 |
$0.024 |
risen by
20%
|
|
CDR - Price-sensitive ASX Announcement
Full Release
Key Points
- Codrus Minerals continued exploration activities at the Karloning Rare Earth Project, reporting positive drilling results.
- Assay results at the Karloning REE Project confirmed the presence of high-grade rare earth elements.
- The Bull Run Gold Project in Oregon, USA, saw preparations for future drilling and ongoing technical work.
- Codrus was awarded a $98,000 grant under the Exploration Incentive Scheme (EIS) to support drilling at Karloning.
- Limited exploration activities occurred at the Silver Swan South and Red Gate Projects during the quarter.
- The company maintained prudent cash management, with significant spending focused on exploration and evaluation.
- The Appendix 5B Cash Flow Report outlined exploration expenditure, operating cash outflows, and the company’s cash position at quarter end.
- Codrus Minerals is focused on advancing its high-priority assets while reviewing new opportunities to enhance shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ampol Limited (ALD) ORDINARY FULLY PAID |
Energy |
$8,102 |
Notification regarding unquoted securities - ALD
|
29 Apr 2025 10:02AM |
$22.620 |
$34.000 |
risen by
50.31%
|
|
Call 1300 880 160
Start a chat
Schedule a call
